Fredun Pharmaceuticals Limited (BOM:539730)
1,715.55
+29.80 (1.77%)
At close: Mar 25, 2026
Fredun Pharmaceuticals Market Cap
Fredun Pharmaceuticals has a market cap or net worth of 8.18 billion as of March 27, 2026. Its market cap has increased by 158.76% in one year.
Market Cap
8.18B
Enterprise Value
9.80B
Revenue
5.91B
Ranking
n/a
PE Ratio
24.06
Stock Price
1,715.55
Market Cap Chart
Since March 28, 2016, Fredun Pharmaceuticals's market cap has increased from 29.41M to 8.18B, an increase of 27,711.54%. That is a compound annual growth rate of 75.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 8.18B | 9.74% |
| Dec 31, 2025 | 7.45B | 115.10% |
| Dec 31, 2024 | 3.46B | -15.14% |
| Dec 29, 2023 | 4.08B | -20.69% |
| Dec 30, 2022 | 5.15B | 37.31% |
| Dec 31, 2021 | 3.75B | 116.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lincoln Pharmaceuticals | 11.87B |
| Venus Remedies | 11.56B |
| TTK Healthcare | 11.05B |
| Syncom Formulations (India) | 10.70B |
| Fermenta Biotech | 10.06B |
| Wanbury | 8.44B |
| Anuh Pharma | 7.17B |
| Bharat Parenterals | 6.84B |